Remix Therapeutics

Akashi Therapeutics, based in Cambridge, is a global biopharmaceutical company with a focus on developing innovative therapies for individuals affected by rare disorders. The company's mission is to create life-changing treatments that address the unmet medical needs of those living with rare diseases, aiming to improve the quality of life for patients worldwide. Generated from their website's infomation

Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.

Rana Therapeutics is a Cambridge-based company that focuses on disease areas, science technology, partnering, sustainable business, and careers. They offer a range of products and services for patients, healthcare professionals, and investors, and are committed to making a positive impact in the healthcare industry. With a strong emphasis on research and development, Rana Therapeutics aims to provide innovative solutions for various diseases. They prioritize accountability and transparency, as evidenced by their financial results, stock information, and press releases. As a reputable company, Rana Therapeutics is dedicated to improving patient outcomes and fostering partnerships within the healthcare community.Generated from the website